Chemed (NYSE:CHE) CEO Sells $806,360.00 in Stock

Key Points

• Chemed CEO Kevin Mcnamara sold 2,000 shares on March 12 at an average price of $403.18 for a total of $806,360, trimming his position by 2.09% to 93,719 shares (≈$37.8M), according to an SEC filing.
• Chemed missed quarterly expectations with EPS of $6.42 versus $7.02 expected and revenue of $639.34M vs. $659.09M, while issuing FY2026 guidance of 23.25–24.25 EPS (analysts forecast ~21.43 EPS).
• The company declared a quarterly dividend of $0.60 per share ($2.40 annualized, ~0.6% yield), with record/ex-dividend date on February 23 and payment scheduled for March 13.

Chemed Corporation (NYSE:CHE - Get Free Report) CEO Kevin Mcnamara sold 2,000 shares of the business's stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the sale, the chief executive officer directly owned 93,719 shares in the company, valued at approximately $37,785,626.42. The trade was a 2.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Chemed Stock Up 0.6%

NYSE CHE traded up $2.31 on Friday, reaching $401.86. 124,709 shares of the stock traded hands, compared to its average volume of 203,754. Chemed Corporation has a 12 month low of $385.00 and a 12 month high of $623.60. The company has a market cap of $5.53 billion, a price-to-earnings ratio of 21.89, a P/E/G ratio of 1.60 and a beta of 0.46. The firm's fifty day simple moving average is $441.92 and its 200 day simple moving average is $441.34.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing analysts' consensus estimates of $7.02 by ($0.60). Chemed had a return on equity of 25.66% and a net margin of 10.48%.The firm had revenue of $639.34 million during the quarter, compared to the consensus estimate of $659.09 million. During the same period in the prior year, the firm posted $6.83 EPS. The firm's quarterly revenue was down .1% on a year-over-year basis. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, equities research analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Monday, February 23rd will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, February 23rd. This represents a $2.40 annualized dividend and a yield of 0.6%. Chemed's dividend payout ratio is currently 13.06%.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Weiss Ratings restated a "hold (c-)" rating on shares of Chemed in a research report on Wednesday, January 21st. Jefferies Financial Group lowered Chemed from a "buy" rating to a "hold" rating in a research note on Thursday, January 22nd. Zacks Research lowered Chemed from a "hold" rating to a "strong sell" rating in a research report on Wednesday, March 4th. Oppenheimer reduced their target price on Chemed from $580.00 to $500.00 and set an "outperform" rating for the company in a report on Friday, February 27th. Finally, Royal Bank Of Canada reiterated a "sector perform" rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $498.00.

Institutional Trading of Chemed

Hedge funds have recently modified their holdings of the business. Monetary Solutions Ltd purchased a new position in shares of Chemed during the fourth quarter valued at $25,000. Los Angeles Capital Management LLC purchased a new stake in Chemed in the 4th quarter worth about $26,000. Smartleaf Asset Management LLC boosted its position in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company's stock worth $27,000 after acquiring an additional 25 shares during the period. BOK Financial Private Wealth Inc. purchased a new position in Chemed during the 4th quarter valued at about $27,000. Finally, First Horizon Corp acquired a new position in shares of Chemed in the 3rd quarter valued at about $31,000. Hedge funds and other institutional investors own 95.85% of the company's stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.